Iambic Therapeutics

Last updated: April 17, 2024

CEO Thomas Miller
CEO Thomas Miller
Country: USA | Funding: $153M (+)

Website: https://www.iambic.ai/

Iambic Therapeutics is built on technologies for predicting protein-ligand structures, generating molecular designs and other drug discovery tasks. Using the technologies, Iambic claims it can accelerate drug discovery, pointing to the two years it took to take its lead project from program launch to IND to make its case.